Wilco

Sep 27, 2017

Exeliom Biosciences joins Wilco Incubator

Mar 4, 2024

Exeliom is awarded a $500k grant from the Crohn's and Colitis Foundation!

#funding #SeriesA #Clinicaltrials

Jun 30, 2023

Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million ($26 Million) to Progress the Clinical Development of its Lead Candidate in Immuno-Oncology and Infectious Diseases.

#Faecalibacterium #GutHealth #HealthResearch #Microbiome #Biotherapeutics #Biotech

Sep 21, 2023

New review on Faecalibacterium published in FEMS Microbiology Reviews explores its potential for human health

contact

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.